Study Information: Major Depressive Disorder (Allergan)

Millions of people suffer from major depression.

Major depressive disorder (MDD) is defined as a period of two weeks or longer during which there is either depressed mood or loss of interest or pleasure, along with other symptoms such as problems with sleep, eating, energy, concentration, and self-image. Major depression is estimated to affect as many as 16 million adults – nearly 7% of all people over 18 – in the U.S.

This clinical study is sponsored by Allergan. 

Study overview here

Finger Lakes Clinical Research (FLCR) is one of approximately…

Dr. Sarah Atkinson is the principal investigator (PI) for this trial. She is a board certified psychiatrist with over twenty years’ experience in the field of central nervous system disorders.

How is the study conducted?

During the first part of the study, you will come to Finger Lakes Clinical Research (at Twelve Corners in Brighton)…

There is no cost to participate, and no insurance is required. Study participants are paid a stipend for time and travel for each visit.

Do you qualify for this study?

Every clinical study requires that participants meet certain criteria. Dr. Atkinson will make a medical determination as to whether you are able to participate, but you can get a quick idea of whether or not you might qualify by answering these three questions:

 

Contact us about this study